Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a
Bio-Path Holdings, Inc. : Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. for Q1 2024. To view the full announcement, including downloadable images, bios, and.
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 24,000 shares, a decrease of 45.9% from the April 30th total of 44,400 shares. Based on an average trading volume of 1,410,000 shares, the short-interest ratio is currently 0.0 […]